bioMérieux (OTCMKTS:BMXMF) Trading Up 3% – Should You Buy?

bioMérieux S.A. (OTCMKTS:BMXMF)’s stock price rose 3% on Friday . The stock traded as high as $103.56 and last traded at $103.56. Approximately 30 shares changed hands during trading, a decline of 49% from the average daily volume of 59 shares. The stock had previously closed at $100.50.

Analysts Set New Price Targets

Separately, UBS Group upgraded shares of bioMérieux to a “strong-buy” rating in a report on Thursday, August 22nd.

bioMérieux Price Performance

The business has a 50-day simple moving average of $111.24 and a 200 day simple moving average of $107.50.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.